Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06511037 · ClinicalTrials.gov registry record · Early Phase 1
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
A Early Phase 1 study of Gastrointestinal Cancer and Peritoneal Carcinomatosis, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06511037: Recruiting Early Phase 1 study of Gastrointestinal Cancer and Peritoneal Carcinomatosis, sponsored by University of California, Irvine.
NCT06511037 is a Early Phase 1 study of Gastrointestinal Cancer and Peritoneal Carcinomatosis that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 10 participants, below the 230-participant average among 49 other Gastrointestinal Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06511037, a Early Phase 1 study of Gastrointestinal Cancer and Peritoneal Carcinomatosis, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot, single-arm, open label study to evaluate the ability of CYTALUX™ (pafolacianine) to help identify cancerous lesions in subjects with gastrointestinal cancers and peritoneal carcinomatosis during cytoreductive surgery.
Primary Outcome
Describe the completeness of cytroreduction (cc) score with Cytoreductive surgery (CRS) with Cytalux injection.
Conditions Studied
Interventions
- DRUG Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging
Study Locations (1)
California
- Chao Family Comprehensive Cancer Center, University of California, Irvine - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-11-13 |
| Est. Completion | 2027-11-30 |
| Phase | Early Phase 1 |
What NCT06511037 shows while recruiting
NCT06511037 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 230-participant average among 49 other Gastrointestinal Cancer trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging is the first listed.
NCT06511037 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06511037 about?
NCT06511037 is a clinical study titled "PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis". This is a pilot, single-arm, open label study to evaluate the ability of CYTALUX™ (pafolacianine) to help identify cancerous lesions in subjects with gastrointestinal cancers and peritoneal carcinomatosis during cytoreductive surgery.
What is the current status of trial NCT06511037?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2024-11-13. Estimated completion is 2027-11-30.
What conditions does trial NCT06511037 study?
This clinical trial studies the following conditions: Gastrointestinal Cancer, Peritoneal Carcinomatosis.
What interventions are being tested in trial NCT06511037?
The interventions under investigation include: Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging (DRUG).
Who is sponsoring clinical trial NCT06511037?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06511037 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06511037's enrollment target sits among peer trials
10 49th of 49 higher than 1 of 49 other Gastrointestinal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastrointestinal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Improving Comprehensive Care of Cancer Patients
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI